Exelon Patch Description

Each transdermal patch releases 4.6 mg of rivastigmine per 24 hours. Each transdermal patch of 5 cm² contains 9 mg of rivastigmine.
Each transdermal patch releases 9.5 mg of rivastigmine per 24 hours. Each transdermal patch of 10 cm² contains 18 mg of rivastigmine.
Each transdermal patch releases 13.3 mg of rivastigmine per 24 hours. Each transdermal patch of 15 cm² contains 27 mg of rivastigmine.
Excipients/Inactive Ingredients: Exelon 4.6 mg/24 h transdermal patch and Exelon 9.5 mg/24 h transdermal patch: Vitamin E, poly butylmethacrylate, methyl-methacrylate, acrylic copolymer, silicone oil (Ph. Eur.). Pharmaceutical formulations may vary between countries.
Exelon 13.3 mg/24 h transdermal patch: Drug product matrix: acrylic pressure sensitive adhesive, poly(butylmethacrylate, methylmethacrylate), tocopherol (all-rac-α), Vitamin E.
Adhesive matrix: silicone pressure sensitive adhesive (contains ethyl acetate), silicone oil 12,500 cSt, Dimethicone, tocopherol (all-rac-α), Vitamin E.
Print Ink: Beige print ink (contains ethyl acetate, ethanol, 1-methoxypropan-2-ol, resin, pigments), Hardener for print ink (contains ethanol, organic polymers/resins (without chlorine)).